Novartis to establish Denton, Texas, radioligand therapy site
We announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, Texas, our fifth in the US.
Relax, It’s a Blood Test: Prostate Cancer Detection on Football’s Biggest Stage
This Super Bowl, Novartis and NFL icons are cutting through the myths: prostate cancer screening can start with a simple PSA blood test – not the potentially uncomfortable exam many men avoid. Novartis teamed up with prostate cancer survivor NFL Coach Bruce Arians and a lineup of the NFL’s most celebrated tight ends to launch a platform that demystifies the process and empowers men to replace hesitation with action and make early detection a priority.
Discover our medicines
See how our innovative medicines are addressing society's greatest health challenges.
Commitment to patients
From research and development to expanding access, uncover our commitment to improving people's lives.
Inspired by purpose
Learn about our people and culture, and how we're driven by our mission to reimagine medicine.
Latest News
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
New real‑world data reinforce earlier use of Pluvicto® before chemotherapy in metastatic castration-resistant prostate cancer
Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)
